Key points are not available for this paper at this time.
NF-kappaB is required for cytokine upregulation of MMP-1, -3 and -9 in VSMCs, which suggests that NF-kappaB inhibition may promote plaque stabilisation.
Mark Bond (Fri,) studied this question.